circRNA_101277 Influences Cisplatin Resistance of Colorectal Cancer Cells by Modulating the miR-370/IL-6 Axis

Background. Colorectal cancer (CRC) is among the most prevalent malignancies globally. Early detection of precancerous lesions through routine colonoscopy has led to a dramatic reduction in CRC-related incidence and mortality among those between the ages of 50 and 70. However, in those where the dis...

Full description

Saved in:
Bibliographic Details
Main Authors: Qing Lv, Qinghua Xia, Anshu Li, Zhiyong Wang
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Genetics Research
Online Access:http://dx.doi.org/10.1155/2022/4237327
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552981066678272
author Qing Lv
Qinghua Xia
Anshu Li
Zhiyong Wang
author_facet Qing Lv
Qinghua Xia
Anshu Li
Zhiyong Wang
author_sort Qing Lv
collection DOAJ
description Background. Colorectal cancer (CRC) is among the most prevalent malignancies globally. Early detection of precancerous lesions through routine colonoscopy has led to a dramatic reduction in CRC-related incidence and mortality among those between the ages of 50 and 70. However, in those where the disease progresses to an advanced stage, chemotherapy remains the primary available treatment option, and the associated 5-year survival rate remains low. The identification of genes associated with CRC chemoresistance would thus be a beneficial approach to identifying novel treatments for this deadly disease. Methods. The expression of circRNA_101277, miR-370, and IL-6 was assessed via qRT-PCR. IL-6 levels were measured with a human IL-6 ELISA kit based on the provided protocols. CRC cellular proliferation and cisplatin IC50 values were quantified via MTT assays. Luciferase assays were used to detect circRNA_101277 and miR-370 binding sites or miR-370 and IL-6 binding sites. Results. circRNA_101277 was increased in CRC tissues compared with control samples. circRNA_101277 overexpression was evident in CRC cells, and knockdown of this circRNA suppressed cellular proliferation and cisplatin resistance in these cancer cells. At a mechanistic level, circRNA_101277 was found to function by sequestering miR-370, thereby upregulating the miR-370 target gene IL-6 and promoting cisplatin resistance via this miR-370/IL-6 axis. Conclusion. In summary, our data highlight circRNA_101277 as a novel driver of CRC cell cisplatin resistance that functions by sequestering miR-370 and thereby enhancing IL-6 expression. These findings suggest that this circRNA_101277/miR-370/IL-6 axis may represent a critical axis of chemoresistance in CRC that can be targeted to diagnose and/or treat this cancer.
format Article
id doaj-art-5c528f0a21fd4c26bbbf4d3e622ed7d6
institution Kabale University
issn 1469-5073
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Genetics Research
spelling doaj-art-5c528f0a21fd4c26bbbf4d3e622ed7d62025-02-03T05:57:20ZengWileyGenetics Research1469-50732022-01-01202210.1155/2022/4237327circRNA_101277 Influences Cisplatin Resistance of Colorectal Cancer Cells by Modulating the miR-370/IL-6 AxisQing Lv0Qinghua Xia1Anshu Li2Zhiyong Wang3Gastrointestinal SurgeryGastrointestinal SurgeryGastrointestinal SurgeryGastrointestinal SurgeryBackground. Colorectal cancer (CRC) is among the most prevalent malignancies globally. Early detection of precancerous lesions through routine colonoscopy has led to a dramatic reduction in CRC-related incidence and mortality among those between the ages of 50 and 70. However, in those where the disease progresses to an advanced stage, chemotherapy remains the primary available treatment option, and the associated 5-year survival rate remains low. The identification of genes associated with CRC chemoresistance would thus be a beneficial approach to identifying novel treatments for this deadly disease. Methods. The expression of circRNA_101277, miR-370, and IL-6 was assessed via qRT-PCR. IL-6 levels were measured with a human IL-6 ELISA kit based on the provided protocols. CRC cellular proliferation and cisplatin IC50 values were quantified via MTT assays. Luciferase assays were used to detect circRNA_101277 and miR-370 binding sites or miR-370 and IL-6 binding sites. Results. circRNA_101277 was increased in CRC tissues compared with control samples. circRNA_101277 overexpression was evident in CRC cells, and knockdown of this circRNA suppressed cellular proliferation and cisplatin resistance in these cancer cells. At a mechanistic level, circRNA_101277 was found to function by sequestering miR-370, thereby upregulating the miR-370 target gene IL-6 and promoting cisplatin resistance via this miR-370/IL-6 axis. Conclusion. In summary, our data highlight circRNA_101277 as a novel driver of CRC cell cisplatin resistance that functions by sequestering miR-370 and thereby enhancing IL-6 expression. These findings suggest that this circRNA_101277/miR-370/IL-6 axis may represent a critical axis of chemoresistance in CRC that can be targeted to diagnose and/or treat this cancer.http://dx.doi.org/10.1155/2022/4237327
spellingShingle Qing Lv
Qinghua Xia
Anshu Li
Zhiyong Wang
circRNA_101277 Influences Cisplatin Resistance of Colorectal Cancer Cells by Modulating the miR-370/IL-6 Axis
Genetics Research
title circRNA_101277 Influences Cisplatin Resistance of Colorectal Cancer Cells by Modulating the miR-370/IL-6 Axis
title_full circRNA_101277 Influences Cisplatin Resistance of Colorectal Cancer Cells by Modulating the miR-370/IL-6 Axis
title_fullStr circRNA_101277 Influences Cisplatin Resistance of Colorectal Cancer Cells by Modulating the miR-370/IL-6 Axis
title_full_unstemmed circRNA_101277 Influences Cisplatin Resistance of Colorectal Cancer Cells by Modulating the miR-370/IL-6 Axis
title_short circRNA_101277 Influences Cisplatin Resistance of Colorectal Cancer Cells by Modulating the miR-370/IL-6 Axis
title_sort circrna 101277 influences cisplatin resistance of colorectal cancer cells by modulating the mir 370 il 6 axis
url http://dx.doi.org/10.1155/2022/4237327
work_keys_str_mv AT qinglv circrna101277influencescisplatinresistanceofcolorectalcancercellsbymodulatingthemir370il6axis
AT qinghuaxia circrna101277influencescisplatinresistanceofcolorectalcancercellsbymodulatingthemir370il6axis
AT anshuli circrna101277influencescisplatinresistanceofcolorectalcancercellsbymodulatingthemir370il6axis
AT zhiyongwang circrna101277influencescisplatinresistanceofcolorectalcancercellsbymodulatingthemir370il6axis